Some possible explanations for these inconsistent results include: (1) different methods, often using a color depth or absorbance concentrations, were used to assess the concentrations of antibodies against PLA2R; (2) low assay sensitivity may have made it difficult to distinguish between different kidney diseases. This evidence concerns the gene PLA2R1 and kidney disorder.